Abstract:Background Hepatocellular carcinoma (HCC) is the major type of primary liver cancer. Intrahepatic metastasis, such as portal vein tumor thrombosis (PVTT), strongly indicates poor prognosis of HCC. But now, there are limited understandings of the molecular features and mechanisms of those metastatic HCCs. Methods To characterize the molecular alterations of the metastatic HCCs, we implemented an integrative analysis of the copy number variations (CNVs), DNA methylations and transcriptomes of matched adjacent normal, primary tumor and PVTT samples from 19 HCC patients. Results CNV analysis identified a frequently amplified focal region chr11q13.3 and a novel deletion peak chr19q13.41 containing three miRNAs. The integrative analysis with RNA-seq data suggests that CNVs and differential promoter methylations regulate distinct oncogenic processes. Then, we used individualized differential analysis to identify the differentially expressed genes between matched primary tumor and PVTT of each patient. Results show that 5 out of 19 studied patients acquire evidential progressive alterations of gene expressions (more than 1000 differentially expressed genes were identified in each patient). While, another subset of eight patients have nearly identical gene expressions between the corresponding matched primary tumor and PVTT. Twenty genes were found to be recurrently and progressively differentially expressed in multiple patients. These genes are mainly associated with focal adhesion, xenobiotics metabolism by cytochrome P450 and amino acid metabolism. For several differentially expressed genes in metabolic pathways, their expressions are significantly associated with overall survivals and vascular invasions of HCC patients. The following transwell assay experiments validate that they can regulate invasive phenotypes of HCC cells. Conclusions The metastatic HCCs with PVTTs have significant molecular alterations comparing with adjacent normal tissues. The recurrent alteration patterns are similar to several previously published general HCC cohorts, but usually with higher severity. By an individualized differential analysis strategy, the progressively differentially expressed genes between the primary tumor and PVTT were identified for each patient. A few patients aquire evidential progressive alterations of gene expressions. And, experiments show that several recurrently differentially expressed genes can strongly regulate HCC cell invasions.

Role of Cell Adhesion Molecules in Occurrence and Metastasis of Hepatocellular Carcinoma

Correlation of nm23 and E-cadherin protein expression with recurrence and metastasis after liver transplantation for hepatocellular carcinoma

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

Study on Metastasis-Associated Gene in Carcinoma by Cdna Microarray

Invasion and Metastasis of Liver Cancer: Expression of Intercellular Adhesion Molecule 1.

The level of serum VCAM-1 in patients with primary hepatocellular carcinoma and its clinical significance

Expression and Clinical Significance of CD146 and VEGF in Hepatocellular Carcinoma

Application of Genechip Technology in Identification of Metastasis-Associated Genes for Hepatocellular Carcinoma

Comprehensive Analysis of the Expression of Cell Adhesion Molecules Genes in Hepatocellular Carcinoma and their Prognosis, and Biological Significance

Gene Expression Profile of Human Hepatocellular Carcinoma Cell Lines with Different Metastatic Potentials

Gene Expression Profiling Of Fixed Tissues Identified Hypoxia-Inducible Factor-1 Alpha, Vegf, And Matrix Metalloproteinase-2 As Biomarkers Of Lymph Node Metastasis In Hepatocellular Carcinoma

Data from Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1α, VEGF, and Matrix Metalloproteinase-2 as Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma

RESEACH ON THE RELATIONSHIP BETWEEN CD146,MICROVESSEL DENSITY OF HEPATOCELLULAR CARCINOMA AND ITS CLINIC-PATHOLOGY

EXPRESSION OF HEPATOCELLULAR CARCINOMA ANTIGEN587 IN HUMAN HEPATOCELLULAR CARCINOMA AND ITS BIOINFORMATICS ANALYSIS

Gene Expression Profiling of Fixed Tissues Identified Hypoxia-Inducible Factor-1Α, VEGF, and Matrix Metalloproteinase-2 As Biomarkers of Lymph Node Metastasis in Hepatocellular Carcinoma.

Screening Candidate Metastasis-Associated Genes in Three-Dimensional HCC Spheroids with Different Metastasis Potential.

Expression and Biological Mechanism Exploration of Hsp27 in Different Metastatic Hcc Cell Lines

The role and mechanisms of NCX1 on proliferation and invasion of hepatocellular carcinoma

Increased Expression of Vascular Endothelial Growth Factor-C and Nuclear Cxcr4 in Hepatocellular Carcinoma is Correlated with Lymph Node Metastasis and Poor Outcome

Integrative molecular analysis of metastatic hepatocellular carcinoma

Advances in research on the role and mechanism of microRNAs in hepatic carcinogenesis